Ritlecitinib is under clinical development by Pfizer and currently in Phase II for Keloids. According to GlobalData, Phase II drugs for Keloids does not have sufficient historical data to build an ...

Purpose: The objective of this study is to investigate the clinical efficacy of sequentially comprehensive treatment based on surgery and to furnish clinical evidence for the management of keloids.

Department of Plastic Surgery, Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China Introduction: Keloids are a common skin disorder characterized by excessive fibrous ...

1Keloid scars on the lips are the most stubborn type of keloid scars. They will not only diminish your appearance but also cause some difficulties in communicating. So how should you get rid of keloid ...